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Summary    28 
Inositol pyrophosphates are novel signaling molecules possessing high-energy pyrophosphate bonds 29 
and involved in a number of biological functions. Here, we report the correct identification and 30 
characterization of the kinases involved in the inositol pyrophosphate biosynthetic pathway in 31 
Trypanosoma brucei: inositol polyphosphate multikinase (TbIPMK), inositol pentakisphosphate 2-32 
kinase (TbIP5K) and inositol hexakisphosphate kinase (TbIP6K). TbIP5K and TbIP6K were not 33 
identifiable by sequence alone and their activities were validated by enzymatic assays with the 34 
recombinant proteins or by their complementation of yeast mutants. We also analyzed T. brucei 35 
extracts for the presence of inositol phosphates using polyacrylamide gel electrophoresis and high 36 
performance liquid chromatography. Interestingly, we could detect inositol phosphate (IP), inositol 37 
4,5-bisphosphate (IP2), inositol 1,4,5-trisphosphate (IP3) and inositol hexakisphosphate (IP6) in T. 38 
brucei different stages. Bloodstream forms unable to produce inositol pyrophosphates, due to 39 
downregulation of TbIPMK expression by conditional knockout, have reduced levels of polyphosphate 40 
and altered acidocalcisomes. Our study links the inositol pyrophosphate pathway to the synthesis of 41 
polyphosphate in acidocalcisomes, and may lead to better understanding of these organisms and 42 
provide new targets for drug discovery. 43 
 44 
Introduction 45 
Myo-inositol is an essential precursor for the synthesis of soluble inositol phosphates (IPs) and lipid-46 
bound inositols called phosphoinositides (PIPs) (Irvine et al., 2001). After inositol incorporation into 47 
the lipid phosphatidylinositol (PI), the inositol ring is phosphorylated to PIPs such as 48 
phosphatidylinositol 4,5-bisphosphate (PIP2) through the action of a phosphatidylinositol phosphate 49 
(PIP) kinase. PIP2 is cleaved by a phosphoinositide phospholipase C (PI-PLC) (Cocco et al., 2015) to 50 
inositol 1,4,5-trisphosphate (IP3) (Fig. 1) and 1,2-diacylglycerol (DAG), which are important second 51 
messengers. While DAG stimulates a protein kinase C (Nishizuka, 1986), IP3 stimulates an IP3 52 
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receptor to release Ca2+ from intracellular stores (Berridge, 2009) and can be further metabolized to 53 
other soluble IPs by several kinases and phosphatases.  54 
The inositol phosphate multikinase (IPMK) has dual 3-kinase/6-kinase activity and catalyzes the 55 
conversion of IP3 into inositol tetrakisphosphate (IP4) and inositol pentakisphosphate (IP5). IP5 is 56 
converted into inositol hexakisphosphate (IP6), the fully phosphorylated myo-inositol also known as 57 
phytic acid, by the 2-kinase activity of inositol pentakisphosphate kinase (IP5K, or IPPK). Further 58 
phosphorylation of IP6 by the inositol hexakisphosphate kinase (IP6 kinase or IP6K) results in the 59 
production of diphosphoinositol polyphosphates (PP-IPs), also known as inositol pyrophosphates. 60 
These are IPs characterized by containing one or more high-energy pyrophosphate moiety. PP-IPs 61 
were discovered in the early 1990’s, in Dictyostelium discoideum (Europe-Finner et al., 1991, Mayr 62 
GW, 1992, Stephens et al., 1993), Entamoeba histolytica (Martin et al., 1993), and in mammalian cells 63 
(Menniti et al., 1993). The best-characterized member of this class is 5-diphosphoinositol 64 
pentakisphosphate (5-PP-P5 or IP7), which has five of the myo-inositol hydroxyls monophosphorylated, 65 
while the sixth, at the 5-position, contains a pyrophosphate group (Albert et al., 1997). The IP6K can 66 
also metabolize IP5 to disphosphoinositol tetrakisphosphate (PP-IP4) (Saiardi et al., 2000, Losito et al., 67 
2009). Another isomer of IP7, containing a pyrophosphate at the 1-position, can also be formed by a 68 
more recently identified enzyme termed diphosphoinositol pentakisphosphate kinase (PP-IP5K), 69 
though this enzyme appears to be predominantly associated physiologically with the formation of 70 
diphosphoinositol hexakisphosphate (PP2-IP4 or IP8) (Choi et al., 2007).  71 
Among the many roles attributed to PP-IPs are the regulation of telomere length (Saiardi et al., 72 
2005, York et al., 2005), DNA repair by homologous recombination (Luo et al., 2002, Jadav et al., 73 
2013), response to hyperosmotic stress (Pesesse et al., 2004, Choi et al., 2007), vesicle trafficking 74 
(Saiardi et al., 2000, Saiardi et al., 2002), apoptosis (Morrison et al., 2001, Nagata et al., 2005), 75 
autophagy (Nagata et al., 2010), binding of pleckstrin homology domains to phospholipids and 76 
proteins (Luo et al., 2003, Gokhale et al., 2013),  transcription of glycolytic enzymes (Szijgyarto et al., 77 
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2011), hemostasis (Ghosh et al., 2013), phagocytic and bactericidal activities of neutrophils (Prasad et 78 
al., 2011), epigenetic modifications to chromatin (Burton et al., 2013) and exocytic insulin secretion 79 
(Illies et al., 2007). PP-IPs may signal through allosteric interaction with proteins (i.e. binding to 80 
pleckstrin homology (PH) or other domains of proteins) or by phosphotransfer reactions (Saiardi, 2012, 81 
Shears, 2015, Wild et al., 2016). The phosphotransfer reaction is non-enzymatic and requires a 82 
phospho-serine residue within an acidic region and consists in adding a second phosphate to the 83 
phosphor-serine resulting in pyrophosphorylation (Saiardi, 2012). 84 
Trypanosoma brucei, which belongs to the group of parasites that causes African trypanosomiasis 85 
(sleeping sickness), possesses a PI-PLC that is stimulated by very low Ca2+ concentrations (King-86 
Keller et al., 2015) and an IP3 receptor that localizes to the acidocalcisomes instead of the endoplasmic 87 
reticulum (Huang et al., 2013). We now found that they also possess orthologs to IPMK, IP5K and 88 
IP6K, but do not have recognizable orthologs to PP-IP5K, inositol 1,4,5-trisphosphate 3-kinases 89 
(ITPKs) and inositol tetrakisphosphate 3-kinase 1 (ITPK1) (Table S1). The ortholog to IPMK 90 
(TbIPMK) was recently reported as essential for the bloodstream forms of the parasites (Cestari et al., 91 
2015), suggesting that the soluble inositol phosphate pathway is essential for the parasite. The 92 
orthologs to IP5K and IP6K were not recognizable by sequence only and were wrongly annotated as a 93 
putative hypothetical protein and as inositol polyphosphate-like protein, respectively. In the present 94 
study, we thoroughly characterized the soluble inositol phosphate pathway of T. brucei. We cloned, 95 
expressed and biochemically characterized the recombinant enzymes from T. brucei, complemented 96 
yeast mutants to demonstrate their function, analyzed their products, studied the inositol phosphate 97 
metabolism of T. brucei cells, and revealed the link of this pathway to the synthesis of polyphosphate 98 
in acidocalcisomes. 99 
 100 
Results 101 
 102 
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Sequence analysis of T. brucei inositol phosphate kinases 103 
 104 
Gene homology searches followed by validation of their activity (see below) have allowed to identify 105 
in the T. brucei genome (http://www.tritrypdb.org/tritrypdb/) the presumably gene orthologs to the 106 
inositol phosphate kinases encoding inositol polyphosphate multikinase (IPMK in mammals, and 107 
Arg82p or Ipk2p in yeast) (Tb427tmp.211.3460); the IP5 kinase (IPPK or IP5K in mammals, and 108 
Ipk1p in yeast) (Tb427.04.1050); and the IP6 kinase (IP6K in mammals, and Kcs1p in yeast) 109 
(Tb427.07.4400), (Fig. 1), and named TbIPMK, TbIP5K, and TbIP6K, respectively (Table S1). No 110 
orthologs to diphosphoinositol pentakisphosphate kinase (PP-IP5K in mammals, or Vip1 in yeasts) 111 
were found, although orthologs to this gene are present in Apicomplexan (Laha et al., 2015) and 112 
Giardia (EuPathDB). The orthologs to TbIPMK, TbIP5K, and TbIP6K identified in T. cruzi 113 
(TcCLB.510741.110, TcCLB.506405.90, TcCLB.504213.90) and Leishmania major (LmjF.35.3140, 114 
LmjF.34.3700, LmjF.14.0340) shared 45%, 36%, 35%, and 29%, 28%, 24% amino acid identity, 115 
respectively. Those of T. brucei share 15%, 16%, and 15% identity with the human enzymes, 116 
respectively. Structural analyses (ELM and TMHMM servers) predicted no transmembrane domains. 117 
A signal peptide was predicted for TbIP5K, but not for TbIPMK or TbIP6K. Mature proteins of 342, 118 
461, and 756 amino acids with predicted molecular weights of 38.8, 51, and 82.6 kDa, for TbIPMK, 119 
TbIP5K, and TbIP6K, respectively, were also predicted. Amino acids 138-147 of TbIPMK, and 588-120 
596 of TbIP6K contained the conserved sequence PCVLDL(I)KL(M)G demonstrated previously as 121 
the putative inositol phosphate binding site that catalyzes the transfer of phosphate from ATP to 122 
inositol phosphates (Bertsch et al., 2000). TbIP5K possesses the sequence PVLDIELL (amino acids 123 
269-276) instead. Both TbIPMK and TbIP6K have a SASLL or TSSLL domain present in most 124 
members of this family of enzymes and required for enzymatic activity (Saiardi et al., 2001b, 125 
Nalaskowski et al., 2002).  126 
  6 
We utilized homologous recombination to add a hemagglutinin (HA) or c-Myc tag to the 127 
endogenous loci (Oberholzer et al., 2006) of TbIPMK, TbIP5K and TbIP6K. All three inositol 128 
phosphate kinases are expressed in procyclic forms (PCF) of T. brucei (Fig. 2A). Although the 129 
predicted MW of TbIP6K is 82.6 kDa the enzyme has multiple phosphorylations (Urbaniak et al., 130 
2013) and these post-translational modifications (in addition to the HA tag) could result in a higher 131 
apparent MW. Interestingly, TbIP5K revealed no expression when using the HA-tag, but a protein 132 
with the expected size was detected when using a c-Myc tag (Fig. 2A). In addition, we tagged the three 133 
IP kinases in T. brucei bloodstream forms (BSF) but no clear bands were detected by western blot 134 
analyses although the tagged genes were expressed at the mRNA level (data not shown), suggesting 135 
that protein expression is lower in BSF than in PCF. 136 
 137 
Characterization of the inositol phosphate multikinase (TbIPMK) 138 
 139 
To characterize the enzymatic activity of TbIPMK we expressed it as fusion protein with an N-140 
terminal polyhistidine tag, purified and tested its activity in vitro. We found that it catalyzes the 141 
formation of IP5 from IP3 or IP4, as detected by polyacrylamide gel electrophoresis (Fig. 2B). Inositol-142 
1,4,5-trisphosphate (I(1,4,5)P3) but not inositol-1,3,4-trisphosphate (I(1,3,4)P3) could be used as 143 
substrate while both inositol-1,3,4,5-tetraphosphate (I(1,3,4,5)P4) and inositol-1,4,5,6-tetraphosphate 144 
(I(1,4,5,6)P4) could be used for the generation of inositol-1,3,4,5,6-pentakisphosphate (I(1,3,4,5,6)P5) 145 
(Fig. 2B), indicating that TbIPMK has a dual 3-kinase/6-kinase activity. An additional product, which 146 
runs closely but not identically to IP6, was also detected when IP3, IP4, or IP5 was used as substrate 147 
(Figs. 2B and 2C). The ability of IPMK to form PP-IP4, an inositol pyrophosphate containing 6 148 
phosphates and thus migrating closely to IP6, has been demonstrated for the mammalian and yeast 149 
ortholog (Saiardi et al., 2001a, Zhang et al., 2001), and we therefore suspected that TbIPMK could 150 
have the same activity. A treatment with perchloric acid (PA), which degrades high-energy 151 
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phosphoanhydride bonds (pyrophosphates) and is inactive against the phosphoester bond of IP6 (Fig. 152 
2C) (Pisani et al., 2014), demonstrated that the highly phosphorylated product of TbIPMK is a 153 
pyrophosphate containing species, therefore PP-IP4. The pH optimum of rTbIPMK was determined. 154 
TbIPMK has the maximum activity for IP3 at the pH range of 6.5-7.0 (Fig. 2D). We also tested the 155 
ability of TbIPMK to phosphorylate different isomers of IP5. Recombinant TbIPMK was able to 156 
phosphorylate I(1,2,4,5,6)P5 and I(1,2,3,4,5)P5 to IP6 after short incubation times, but it was not able to 157 
use I(2,3,4,5,6)P5,  I(1,3,4,5,6)P5, (I(1,2,3,5,6)P5, or (I(1,2,3,4,6)P5 as substrate (Fig. 2E). Although 158 
I(1,2,4,5,6)P5 and I(1,2,3,4,5)P5 would not be physiological substrates, the results again confirms a 159 
3/6-kinase activity. Interestingly, TbIPMK could also phosphorylate I(1,4)P2 to IP4 (Fig. 2B). The 160 
mammalian IPMK has been reported to have PI3-kinase activity that produces PIP3 from PIP2 161 
(Resnick et al., 2005). However, our in vitro activity tests using PIP2 as substrate revealed no such 162 
activity (data not shown) in agreement with the results of a previous report (Cestari et al., 2016). 163 
 The ability of TbIPMK to act on IP3 in vivo was tested by complementation of a null mutant for its 164 
ortholog ARG82 (arg82 in Saccharomyces cerevisiae. Fig. 3A shows the HPLC analysis of soluble 165 
inositol phosphates isolated from yeast labeled with [3H]inositol. Arg82p phosphorylates IP3 to 166 
produce IP4 and IP5, and in its absence there is accumulation of IP3, instead of the accumulation of IP6 167 
that occurs in wild type yeast (Fig. 3A). The metabolic pathway from IP3 to IP6 was restored by 168 
complementation with TbIPMK (Fig. 3A). These results indicate that TbIPMK function as part of the 169 
IP6 biosynthetic pathway established in yeast (York et al., 1999). We also examined the ability of 170 
TbIPMK to rescue the growth defect of arg82 yeast. Complementation of arg82 with TbIPMK 171 
rescued their growth defect (Fig. 3B, and 3C). Therefore, TbIPMK was able to complement yeast 172 
deficient in its ortholog Arg82p, providing molecular evidence of its function. The results also suggest 173 
that the pathway for IP5 synthesis is similar to that present in yeast with conversion of I(1,4,5)P3 into 174 
I(1,4,5,6)P4 and I(1,3,4,5,6)P5, TbIPMK acting as a 3/6-kinase. This is different from the pathway for 175 
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synthesis of I(1,3,4,5,6)P5 present in humans, where the major activity of IP4 kinase is phosphorylation 176 
at the D-5 position (Chang et al., 2002).  177 
 178 
Characterization of the inositol pentakisphosphate kinase (TbIP5K) 179 
 180 
Although expression of polyhistidine-tagged TbIP5K was obtained in bacteria and the recombinant 181 
protein had the expected molecular mass, we were not able to detect its activity in vitro, even in the 182 
presence of different isomers of IP5 (data not shown) suggesting that additional post-translational 183 
modifications are needed. In this regard, activity of human IP5K could only be obtained when 184 
expressed in insect cells (Verbsky et al., 2002). However, TbIP5K was able to complement null 185 
mutant yeast deficient in its ortholog IPK1 (Ipk1) (Fig. 3D). Ipk1p phosphorylates IP5 to produce IP6, 186 
and in its absence there is accumulation of IP5, instead of the accumulation of IP6 that occurs in wild 187 
type yeast. The metabolic pathway from IP5 to IP6 was restored by complementation with TbIP5K (Fig. 188 
3D). The presence of a shoulder close to the PP-IP4 eluting peak in the mutant yeast suggests the 189 
existence of two isomeric PP-IP4 species. We also complemented yeast mutants for both ipk1 (IP5K) 190 
and kcs1 (IP6K). These mutants accumulate IP2, IP3, IP4, and IP5 but no PP-IPs. While 191 
complementation with either TbIPMK or TbIP6K (not shown) alone did not change appreciably the 192 
inositol polyphosphate profile, synthesis of IP6 was restored by complementation with TbIP5K alone 193 
(Fig. 3E), demonstrating that TbIP5K is the only inositol phosphate kinase identified in T. brucei 194 
genome that can produce IP6. 195 
 196 
Characterization of the inositol hexakisphosphate kinase (TbIP6K) 197 
 198 
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TbIP6K catalyzes the formation of IP7 from IP6. TbIP6K was also tagged with an HA tag using 199 
homologous recombination with the endogenous gene loci (Oberholzer et al., 2006). We detected 200 
expression of the enzyme in T. brucei procyclic forms (PCF) by western blot analysis (Fig. 2A). 201 
Recombinant TbIP6K was found to generate PP-IP4 from IP5 and IP7 from IP6 (Fig. 4A). Interestingly 202 
TbIP6K was not able to generate IP8 using a 5PP-IP7 as substrate, which suggests that, as IP6K from 203 
yeast and mammals, TbIP6K phosphorylates phosphate position D-5. Therefore, TbIP6K is able to 204 
generate two PP-IPs in vitro: PP-IP4, and IP7. The activity of TbIP6K was tested in vivo by 205 
complementation of a null mutant for its IP6K ortholog (KCS1) in S. cerevisiae. In the absence of 206 
KCS1 there is no accumulation of IP7, but the metabolic pathway from IP6 to IP7 is restored by 207 
complementation with TbIP6K (Fig. 4B). Complementation of Kcs1 TbIP6K also rescued the growth 208 
defect of these mutants (Fig. 4C and 4D). The TbIP6K enzymatic activity has optimum pH 6.0-7.0 209 
(Fig. 4E). 210 
  211 
Characterization of inositol phosphates from T. brucei cells  212 
 213 
Previous attempts to characterize soluble inositol phosphates from T. brucei (Moreno et al., 1992) and 214 
T. cruzi (Docampo et al., 1991) only detected IP, IP2 and IP3. We used increased labeling time to 40 215 
hours (BSF) and 75 hours (PCF) with [3H]inositol and used an improved protocol for purifying and 216 
analyzing inositol phosphates (see Materials and methods). Using these conditions, we were able to 217 
detect a small peak of IP6 in PCF but not in BSF of the parasite (Figs. 5A, and 5B). The inability to 218 
detect radiolabeled IP6 in the BSF might simply reflect the lower number of cells that can be obtained 219 
in culture. To improve the detection of IP6 we used a different approach that does not require 220 
metabolic labeling with [3H]inositol. We extracted IPs from large amounts of cells (see Materials and 221 
methods) and assayed extracts by 35% polyacrylamide gel electrophoresis (PAGE). A band that runs 222 
like the IP6 standard and that disappears after treatment of the extracts with phytase (Phy) was 223 
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observed in both PCF and BSF (Figs. 5C, and 5D). Other highly phosphorylated inositol phosphates 224 
were not detected. These results confirm that both PCF and BSF TbIPMK and TbIP5K can 225 
sequentially synthesize IP6 in T. brucei. 226 
 227 
Biological relevance of the TbIPMK pathway 228 
 229 
Yeast lacking Arg82p have no observable inorganic polyphosphate accumulation (Lonetti et al., 2011). 230 
As polyphosphate has important roles in trypanosomes, including growth, response to osmotic stress, 231 
and maintenance of persistent infections (Lander et al., 2016), we investigated whether deletion of 232 
soluble inositol polyphosphates affected the levels of polyphosphate in T. brucei. We used the 233 
TbIPMK conditional knockout BSF cell line previously described (Cestari et al., 2015). Removal of 234 
tetracycline to induce the knockdown of TbIPMK dramatically reduced its expression more than 100-235 
fold (Fig. 6A). Growth stalled after the first day without tetracycline (Fig. 6B). A resulting progressive 236 
reduction in polyphosphate levels was detected (Fig. 6C). Acidocalcisomes are the main cellular 237 
storage compartment for polyphosphate in trypanosomes (Lander et al., 2016). However, examination 238 
of the cells by super-resolution microscopy with antibodies against the vacuolar proton 239 
pyrophosphatase (TbVP1) showed no apparent difference in labeling or distribution of 240 
acidocalcisomes between control and TbIPMK mutant cells (Figure S1). In previous work we 241 
demonstrated that a knockdown of the TbVtc4, which catalyzes the synthesis and translocation of  242 
polyphosphate into acidocalcisomes, results in less electron-dense organelles, as examined by electron 243 
microscopy (Ulrich et al., 2014). We hypothesized that if the polyphosphate reduction observed (Fig. 244 
6C) was primarily within acidocalcisomes, we should observe similar changes in the TbIPMK mutant 245 
cells. Indeed, electron microscopy of the TbIPMK mutants showed a reduction in the number (Fig. 6D), 246 
size, and electron density (compare Fig. 6E and 6F) of electron-dense organelles identifiable as 247 
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acidocalcisomes. This result indicates that acidocalcisome polyphosphate synthesis is disrupted by 248 
ablation of the inositol phosphate signaling pathway.  249 
 250 
Discussion 251 
 252 
Our work establishes the presence of an inositol pyrophosphate (PP-IPs) synthesis pathway in T. 253 
brucei. We demonstrated that genes encoding proteins with homology to kinases involved in the 254 
generation of IP5 from IP4 and IP3 (TbIPMK), of IP6 from IP5 (TbIP5K), and of IP7 from IP6 (TbIP6K) 255 
are present in the T. brucei genome (TbIPMK, TbIP5K, and TbIP6K). To demonstrate that these genes 256 
encode for functional enzymes we complemented yeast strains deficient in their corresponding 257 
orthologs and compared their products with those produced in the wild type strain providing in vivo 258 
genetic evidence of their function. We did not compare them with the knockout strains overexpressing 259 
the endogenous genes because the heterologous gene expression is often hampered by a diverse 260 
genetic code usage and by the lack of yeast specific post-translational processing. Thus, the 261 
heterologous genes are regularly expressed from a stronger promoter. The overexpressing of the 262 
endogenous gene from a stronger promoter might generate, to the contrary, ‘hyper’ phenotype and not 263 
a normal WT phenotype and our aim was to demonstrate their function and not to compare their 264 
activities to those of the overexpressed endogenous genes. Suppression of this pathway in T. brucei 265 
BSF resulted in a significant decrease in polyphosphate levels and in morphological alterations of the 266 
acidocalcisomes. The results suggest that this pathway is important for polyphosphate synthesis in 267 
acidocalcisomes. 268 
Examination of the protein sequences of TbIPMK, TbIP5K, and TbIP6K indicated low identity 269 
with the mammalian enzymes but conservation of the putative binding site that catalyzes the transfer 270 
of phosphate from ATP to IPs, as well as of other domains required for enzymatic activity. The 271 
expression of these three kinases is very low in BSF since no clear bands were detected by western 272 
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blot analyses of endogenous tagged lines, although gene expression is detectable at the mRNA level. 273 
Conversely, all three kinases can be easily identified by western blot analysis of PCF. Our results 274 
suggest, in agreement with the presence of these enzymes in other unicellular organisms such as D. 275 
discoideum (Europe-Finner et al., 1991, Mayr GW, 1992, Stephens et al., 1993), and E. histolytica 276 
(Martin et al., 1993), an early emergence of this pathway preceding the origin of multicellularity. 277 
The application of polyacrylamide gel electrophoresis (PAGE) and toluidine blue staining (Losito 278 
et al., 2009, Pisani et al., 2014) allowed the characterization of the IPs synthesizing kinases of T. 279 
brucei and the identification of the products of each reaction bypassing the need for extraction under 280 
the strong acidic conditions required for HPLC analysis that has been shown to degrade some of the 281 
most highly phosphorylated species (Losito et al., 2009). 282 
Previous work has indicated that TbIPMK is essential for growth (Cestari et al., 2015) and 283 
infectivity (Cestari et al., 2016) of T. brucei BSF, and partially characterized the recombinant enzyme 284 
(Cestari et al., 2016). We confirmed that TbIPMK prefers I(1,4,5)P3 and I(1,3,4,5)P4 as substrates 285 
(Cestari et al., 2016) and found that it does not phosphorylate I(1,3,4)P3. We also confirmed that 286 
TbIPMK cannot phosphorylate the lipid PIP2 to PIP3 (Cestari et al., 2016), as the human enzyme does 287 
(Resnick et al., 2005). In addition, we found that the enzyme can use I(1,3,4,5)P4 and I(1,4,5,6)P4 for 288 
the generation of I(1,3,4,5,6)P5 indicating that TbIPMK has a dual 3-kinase/6-kinase activity. This is 289 
in contrast to the human enzyme, where the major activity of IP4 kinase is phosphorylation at the D-5 290 
position (Chang et al., 2002). Moreover, we demonstrated that TbIPMK is able to generate PP-IP4
 in 291 
vitro, using either I(1,4,5)P3, I(1,3,4,5)P4 or I(1,3,4,5,6)P5, as well as IP6 from  I(1,2,4,5,6)P5, or 292 
(I(1,2,3,4,5)P5 as substrate, again indicating a 3/6-kinase activity. TbIPMK has a neutral pH optimum 293 
for phosphorylation of both IP3 and IP4. Previous work (Cestari et al., 2016) described inhibitors of 294 
this enzyme that inhibited T. brucei BSF growth. However, their IC50s against the enzymes were 295 
higher (3.4-5.33 µM) than the EC50s for their growth inhibition (0.51-0.83 µM), suggesting that either 296 
the drugs are accumulated or other targets might be involved in the sensitivity of T. brucei BSF to 297 
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those inhibitors. The search for more specific inhibitors is warranted to demonstrate the relevance of 298 
this pathway to human disease and drug therapy. Interestingly, a recombinant multi-domain protein 299 
from Plasmodium knowlesi termed PkIPK1 was shown to have IPMK-like activity and was able to 300 
generate I(1,3,4,5)P4 from I(1,4,5)P3 and I(1,2,4,5,6)P5 from either I(1,2,5,6)P4 or I(1,3,4,6)P4, 301 
showing 3/5-kinase activity (Stritzke et al., 2012). 302 
We were not able to detect activity of the recombinant IP5K in the presence of different isomers of 303 
IP5 suggesting that, as proposed for the mammalian enzyme, post-translational modifications are 304 
needed for its activity (Verbsky et al., 2002). However, TbIP5K was able to complement null mutant 305 
yeast deficient in its ortholog IPK1 (Ipk1, providing genetic evidence of its function.  306 
Recombinant TbIP6K was able to generate PP-IP4 from IP5 and IP7 from IP6, but was not able to 307 
generate IP8 using a 5-PP-IP5 as substrate suggesting that, as IP6K from mammalian cells (Draskovic 308 
et al., 2008), TbIP6K phosphorylates phosphate at position D-5. Therefore, TbIP6K is able to generate 309 
two PP-IPs in vitro: PP-IP4, and IP7. Complementation of yeast deficient in its ortholog confirmed the 310 
function of this enzyme.  311 
T. brucei incorporates poorly the radioactive tracer [3H]inositol a feature previously observed in 312 
Dictyostelium discoideum (Losito et al., 2009). Nevertheless, improved metabolic labeling with 313 
[3H]inositol resulted in detection of IP, IP2, IP3 and IP6 by HPLC analysis of PCF extracts. In contrast 314 
to the results obtained using similar methods in yeasts (Azevedo et al., 2006), plants (Phillippy et al., 315 
2015) or animal cells (Guse et al., 1993), only very low levels of IP6 were detected and no labeled IP6 316 
was detected by HPLC using BSF extracts. However, IP6 was clearly detected by PAGE and toluidine 317 
blue staining when large numbers of parasites were used. No inositol pyrophosphates were detected 318 
since to purify and visualize IPs we removed the abundant inorganic polyphosphate (polyP) by acidic 319 
treatment, procedure that would degrade IP7 to IP6. However, the absence of IP7 could be also 320 
attributed to the high turnover of these important signaling molecules (Glennon et al., 1993, Burton et 321 
al., 2009). Some cells accumulate IP6 and produce IP7 upon signaling events. For instance, 322 
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Cryptococcus neoformans requires synthesis of IP7 for successful establishment of infection (Li et al., 323 
2016). A recent study demonstrated that IP7 binds the SPX domain of proteins involved in phosphate 324 
homeostasis in plants, yeast and humans with high affinity and specificity and postulated the role of 325 
this domain as a polyphosphate sensor domain (Wild et al., 2016, Azevedo et al., 2017). Two proteins 326 
in T. brucei possess SPX domains, TbVtc4 (Lander et al., 2013), which is involved in polyphosphate 327 
synthesis and translocation, and TbPho91 (Huang et al., 2014), a phosphate transporter. Both proteins 328 
localize to acidocalcisomes (Huang et al., 2014), the main polyphosphate storage of these cells. Our 329 
results, showing lower levels of polyphosphate and altered acidocalcisomes in TbIPMK BSF mutants, 330 
support the link between PP-IPs and polyphosphate metabolism. 331 
In summary, both recombinant enzymes, TbIPMK and TbIP6K, are able to generate inositol 332 
pyrophosphates. The essentiality of the first enzyme of this pathway, TbIPMK, for growth and 333 
infectivity of T. brucei BSF (Cestari et al., 2015, Cestari et al., 2016) suggests that the study of the PP-334 
IPs pathway in trypanosomes could lead to the elucidation of potentially multiple important roles of 335 
these compounds, possibly linked to the synthesis of polyphosphate. Differences between mammalian 336 
and trypanosome metabolism of these compounds could provide potential targets for drug 337 
development.  338 
 339 
Experimental procedures 340 
 341 
Chemicals and reagents 342 
 343 
Mouse antibodies against HA were from Covance (Hollywood, FL). Inositol, myo-[1,2-3H(N)] (30-80 344 
Ci/mmol, ART 0261A) was from American Radiolabeled Chemicals, Inc. Goat anti-mouse antibodies 345 
were from LI-COR Biosciences (Lincoln, NE). Laemmli sample buffer was from Bio-Rad 346 
Laboratories (Hercules, CA). The bicinchoninic (BCA) protein assay kit was from Pierce (Thermo 347 
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Fisher Scientific, USA). Titanium dioxide (TiO2) beads (Titansphere ToO 5 µm) were from GL 348 
Sciences (USA). PrimeSTAR HS DNA polymerase was from Clontech Laboratories Inc. (Takara, 349 
Mountain View, CA). Vector pET32 Ek/LIC was from Novagen (Merck KGaA, Darmstadt, Germany). 350 
Acrylamide mix was from National Diagnostics (Chapel Hill, NC). CelLytic M cell lysis reagent, 351 
P8340 protease inhibitor, protease inhibitors, Benzonase Nuclease, antibody against c-Myc, inositol 352 
phosphates, and other analytical reagents were from Sigma-Aldrich (St. Louis, MO). 353 
 354 
Cell cultures 355 
 356 
T. brucei Lister strain 427 BSF and PCF were used. The BSF were cultivated at 37ºC in HMI-9 357 
medium (Hirumi et al., 1989) supplemented with 10% heat inactivated fetal bovine serum (FBS, 358 
Sigma). The PCF were cultivated at 28oC in SDM-79 medium (Cunningham, 1977) supplemented 359 
with 10% heat-inactivated FBS and hemin (7.5 µg/ml). To determine the presence of IP6 by PAGE 360 
analysis T. brucei BSF were also isolated from infected mice (Balb/c, female, 6-8 weeks old) and rats 361 
(Wistar, male retired breeders), as described previously (Cross, 1975). T. brucei IPMK conditional 362 
knockout cell line was obtained and grown as described previously (Cestari et al., 2015). 363 
 364 
Yeast strains 365 
 366 
The yeast strains used in this study are isogenic to DDY1810 (MATa leu2-3,112 trp1-Δ901 ura3-52 367 
prb1-1122 pep4-3 prc1-407), except for the ipk1kcs1 strain that is isogenic to BY4741 (MATa 368 
his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) and was previously described (Saiardi et al., 2002). The DDY1810 369 
protease deficient strain is often used to increase the expression of exogenous proteins upon 370 
overexpression due to a deletion on the Pep4 protease. The generation of DDY1810 kcs1 strain was 371 
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previously described (Onnebo et al., 2009). The arg82, ipk1 yeast strains in the DDY1810 genetic 372 
background were generated following standard homologous recombination techniques (Gueldener et 373 
al., 2002) using oligonucleotides listed in Table S2. Initially diagnostic PCR was performed to confirm 374 
the correct integration of the deletion constructs. Subsequently, the soluble inositol polyphosphate 375 
profile of these new strains was used to phenotypically validate the correct homologous recombination 376 
event. 377 
 378 
Epitope tagging, cloning expression and biochemical characterization of inositol phosphate kinases 379 
 380 
We followed a one-step epitope-tagging method (Oberholzer et al., 2006) to produce the C-terminal 381 
HA- or cMyc-tagging cassettes for transfection of T. brucei PCF (Table S2). Briefly, the tagging 382 
cassettes containing selection markers were generated for cell transfection by PCR using pMOTag4H 383 
and pMOTag33M as templates with the corresponding PCR primers of the genes (Table S2). 384 
Transfection was performed using 2.5 x 107 PCF parasites from log phase. Cells were harvested at 385 
1,000 x g for 10 min, washed with 10 ml of ice-cold sterile Cytomix buffer (2 mM EGTA, 3 mM 386 
MgCl2, 120 mM KCl, 0.5% glucose, 0.15 mM CaCl2, 0.1 mg/ml bovine serum albumin, 10 mM 387 
K2HPO4/KH2PO4, 1 mM hypoxanthine, 25 mM Hepes, pH 7.6), centrifuged at 1,000 x g for 7 min, 388 
suspended in 0.5 ml Cytomix and transferred to an ice-cold 4 mm gap cuvette (Bio-Rad) containing 15 389 
µg of PCR amplicon. Cuvettes were incubated 5 min on ice and immediately electroporated twice in 390 
Bio-Rad GenePulser XcellTM Electroporation System at 1.5 kV, 25 µF. Cuvettes were kept on ice for 391 
one minute between electroporation pulses. Cell mixture was transferred to SDM-79 medium with 392 
15% FBS. After 6 h appropriate antibiotics were added. The sequences of the three kinases TbIPMK, 393 
TbIP5K and TbIP6K were amplified from genomic DNA by PCR (Table S2) using PrimeSTAR HS 394 
DNA polymerase and cloned into ligation independent expression vector pET32 Ek/LIC, as 395 
recommended by the manufacturer. Constructs were cloned into Escherichia coli BL21-396 
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CodonPlus(DE3) and protein expression was induced with 1 mM isopropyl β-D-1-397 
thiogalactopyranoside (IPTG) in Luria Bertani broth for 3 h. Protein purification was performed using 398 
affinity chromatography HIS-Select® Cartridge, according to the manufacturer's instructions. We 399 
tested activity of the kinases on commercially available substrates. Enzyme assays were performed at 400 
37°C using approximately 50 ng of recombinant protein, 20 mM Hepes buffer, pH 7.0, 0.2-0.5 mM 401 
substrate, 6 mM MgCl2, 100 mM NaCl, 1 mM dithiotreitol (DTT), 0.5 mM ATP, 10 mM 402 
phosphocreatine, and 40 U creatine kinase. Enzymatic reactions were stopped with 3 µl of 100 mM 403 
EDTA and kept on ice or frozen until further use. Reaction products were resolved by PAGE using 404 
35% acrylamide/bis-acrylamide 19:1 gels in Tris/Borate/EDTA (TBE) buffer as described by (Losito 405 
et al., 2009). Gels were stained with toluidine blue (Losito et al., 2009). 406 
 407 
RNA quantification 408 
 409 
The TbIPMK conditional knockout cell line was grown with or without 1 µg/ml tetracycline and 410 
harvested at room temperature. RNA was extracted with TRI reagent (Sigma) and used as template for 411 
cDNA synthesis with SuperScript III RNA Polymerase (ThermoFisher) and oligo-dT as recommended 412 
by the manufacturer.  We then performed qRT-PCR analysis using specific primers (Table S2) and 413 
SYBR Green Supermix (Bio-Rad). Relative TbIPMK gene expression relative to actin was calculated 414 
using CFX Manager™ Software (Bio-Rad). 415 
 416 
Western blot analyses 417 
 418 
Cells were harvested, washed twice in PBS, and lysed with CelLytic M cell lysis reagent containing 419 
protease inhibitor cocktail (Sigma P8340) diluted 1:250, 1 mM EDTA, 1 mM phenylmethanesulfonyl 420 
fluoride (PMSF), 20 µM trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E64) and 50 U/ml 421 
  18 
Benzonase Nuclease (Millipore). The protein concentration was determined by using a BCA protein 422 
assay kit. The total cell lysates were mixed with 2X Laemmli sample buffer at 1:1 ratio (vol/vol) and 423 
directly loaded in 10% SDS-PAGE. The separated proteins were transferred onto nitrocellulose 424 
membranes using a Bio-Rad transblot apparatus. The membranes were blocked with 5% (wt/vol) 425 
nonfat milk in PBS containing 0.5% Tween-20 (PBS-T) at 4ºC overnight. The blots were incubated for 426 
1 hour with mouse antibodies against HA (1:1000) or mouse antibodies against c-Myc (1:1000). After 427 
five washings with PBS-T the blots were incubated with goat anti-mouse antibodies at a dilution of 428 
1:15000 and developed using an Odyssey CLx Infrared Imaging System (LI-COR) according to the 429 
manufacturer instructions.  430 
 431 
Yeast complementation   432 
 433 
S. cerevisiae strains generated from DDY1810 were used: arg82Δ, ipk1Δ, kcs1Δ, ipk1Δkcs1Δ. 434 
TbIPMK, TbIP5K and TbIP6K were amplified from T. brucei Lister 427, cloned into plasmid 435 
pADH:GST (pYES-ADH1-GST) (Azevedo et al., 2009). Yeast cells were grown for 48 h in CSM 436 
plates. One colony was collected and suspended in 0.2 M lithium acetate with 25% polyethylene 437 
glycol solution and 0.1 M DTT. Cells were homogenized in 100 µl of solution with 100 ng of plasmid 438 
DNA and 5 µl of salmon sperm (Sigma D76560). Cells were incubated at 42oC for 30 min and 439 
immediately plated in CSM -URA plates. Colonies were used for further experiments. 440 
 441 
Titanium dioxide bead extraction 442 
 443 
We adapted the method of Wilson et al. (Wilson et al., 2015) for cell extraction of inositol 444 
polyphosphates. Cells (5 x 109) were harvested and washed twice in washing buffer A with glucose 445 
(BAG, 116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO4, 50 mM Hepes, ph 7.3, and 5.5 mM glucose). 446 
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The pellet was then mixed with 1 M perchloric acid, resuspended by sonication (40% amplitude) for 447 
10 s and kept at room temperature for 15 min. The sample was centrifuged art 18,000 x g for 5 min 448 
and the supernatant was transferred to a new tube and boiled for 30 min to remove the large amount of 449 
polyphosphate present in T. brucei. Seven mg of TiO2 beads were washed with water and 1 M 450 
perchloric acid, and added to the sample and left rotating for 30 min. Beads were centrifuged at 3,500 451 
x g and inositol phosphates eluted with 1 M KOH, 10 mM EDTA. The sample was neutralized with 452 
perchloric acid and split into two. One half was digested with phytase (0.1 mg/ml) in the same medium 453 
at pH 5.0 and 37oC for 1 h. Extracts were resolved by 35% PAGE analysis as described above.  454 
 455 
HPLC analysis 456 
 457 
Inositol phosphate analysis was performed according to (Azevedo et al., 2006). Briefly, yeast liquid 458 
cultures were diluted to OD600 0.005 in inositol free media supplemented with 5 µCi/ml [
3H] inositol 459 
and grown overnight at 30oC with shaking. Cells were washed twice with water and immediately 460 
incubated with ice-cold 1 M perchloric acid and 3 mM EDTA. Glass beads were added and cells lysed 461 
by vortexing at 4oC for 2 min, 3 times. Lysates were centrifuged and supernatants neutralized with 1 462 
M K2CO3 and 3 mM EDTA. Samples were analyzed by strong anion exchange HPLC using SAX 463 
4.6125 mm column (Whatman cat. no. 4621-0505). The column was eluted with two slightly different 464 
gradients generated by mixing buffer A (1 mM Na2EDTA) and buffer B [buffer A plus 1.3 M 465 
(NH4)2HPO4 (pH 3.8 with H3PO4)] as follows: 0–5 min, 0% B; 5–10 min, 0–30% B; 10–60 min, 30–466 
100% B; 60–80 min, 100% B; or as follow: 0–5 min, 0% B; 5–10 min, 0–10% B; 10–85 min, 20–467 
100% B; 85–100 min 100% B. Four mL of Ultima-Flo AP liquid scintillation cocktail (Perkin-Elmer 468 
cat. no. 6013599) was added to each fraction, mixed and radioactivity quantified in a scintillation 469 
counter.  470 
 471 
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T. brucei labeling for HPLC analysis 472 
 473 
T. brucei PCF (~3x106 cells) were labeled with 5 µCi/ml of 1,2-[3H]-inositol in SDM-79 medium 474 
(with 10% FBS) and grown for approximately 72 h. T. brucei BSF (~2x105 cells) were labeled with 5 475 
µCi/ml of 1,2-[3H]-inositol in HMI-9 medium (with 10% FBS) and grown for approximately 40 h. 476 
Cells were washed with PBS or BAG twice and frozen immediately. Soluble inositol phosphates were 477 
extracted and analyzed as described before (Azevedo et al., 2006), with minor modifications. Briefly, 478 
cells were suspended in ice-cold perchloric acid and broken by vortexing for 2 min. All steps were 479 
performed at 4oC. Lysates were centrifuged for 5 min at 18,000 x g and supernatants transferred to 480 
new tubes, where the pH was neutralized with 1 M K2CO3 and 3 mM EDTA. Samples were stored at 481 
4oC and resolved by HPLC. 482 
 483 
Polyphosphate extraction and measurement 484 
 485 
Short chain polyphosphate was extracted from BSF T. brucei and quantified as described previously 486 
(Ulrich et al., 2014). 487 
 488 
Immunofluorescence Assay 489 
T. brucei BSF were washed with BAG and fixed with 2% paraformaldehyde in BAG for 1 h at room 490 
temperature. Then they were adhered to poly-L-lysine coated coverslips and permeabilized with 0.1% 491 
Triton X-100 in PBS for 5 min. Blocking was performed overnight at 4oC in PBS containing 100 mM 492 
NH4Cl, 3% BSA, 1% fish gelatin and 5% goat serum. Cells were then incubated with anti-TbVP1 493 
polyclonal Guinea pig antibody (1:100) for 1 h and subsequently with Alexa 488-conjugated goat anti-494 
Guinea pig antibody (1:1000) for 1h. Microscopy images were taken with a 100X oil immersion 495 
objective, a high-power solid-state 405 nm laser and EM-CCD camera (Andor iXon) under 496 
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nonsaturating conditions in a Zeiss ELYRA S1 (SR-SIM) super resolution microscope. Images were 497 
acquired and processed with ZEN 2011 software with SIM analysis module.  498 
 499 
Electron microscopy 500 
Imaging of whole T. brucei BSF and determination of morphometric parameters were done as 501 
described previously (Ulrich et al., 2014). 502 
 503 
Statistical analysis 504 
 505 
All experiments were repeated at least three times (biological replicates) with several technical 506 
replicates as indicated in the figure legends, and where indicated results are expressed as means ± s.d. 507 
or s.e.m. of n experiments. Statistical analyses were performed using the Student’s t-test. Results are 508 
considered significant when P < 0.05. 509 
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Abbreviated Summary 533 
The work identifies the enzymes involved in the inositol pyrophosphate synthesis pathway in 534 
Trypanosoma brucei and establishes a link between this pathway and the synthesis of polyphosphate 535 
in acidocalcisomes. 536 
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FIGURE LEGENDS 725 
 726 
Fig. 1. Inositol phosphate pathway in Trypanosoma brucei. The soluble IP pathway starts with 727 
hydrolysis of PIP2 by TbPI-PLC1, releasing IP3 that is phosphorylated by TbIPMK to generate IP4 and 728 
IP5. IP5 is phosphorylated by TbIP5K to generate IP6. IP5 and IP6 can be further phosphorylated by 729 
TbIPMK or TbIP6K to generate inositol pyrophosphates PP-IP4 and IP7. Names of the equivalent yeast 730 
enzymes are in green. 731 
 732 
Fig. 2. Western blot analyses and enzymatic activity of TbIPMK.  733 
A. Western blot analyses of T. brucei PCF expressing epitope-tagged TbIPMK, TbIP5K and TbIP6K. 734 
Left panel are HA tagged cell lines: 1, wild-type; 2, TbIPMK-HA; 3, wild-type; 4, TbIP6K-HA. Right 735 
panel is a c-Myc tagged line: 5, wild-type; 6, TbIP5K-cMyc.  736 
  31 
B. Kinase reactions performed with recombinant TbIPMK (2 µg) using the indicated substrates at 250 737 
µM for 1 hour at 37ºC. TbIPMK can phosphorylate I(1,4,5)P3 but not I(1,3,4)P3 to produce I(1,3,4)P5 738 
and PP-IP4, and can phosphorylate I(1,3,4,5)P4, and I(1,4,5,6)P4 to produce IP5 and PP-IP4. It can also 739 
phosphorylate I(1,3,4,5,6)P5 to PP-IP4. Other arrows show bands corresponding to ATP, IP4, and IP3. 740 
TbIPMK can phosphorylate I(1,4)P2 to produce IP4, and I(1,4,5)P3 to produce IP5 and PP-IP4.  741 
C. Treatment of the sample with perchloric acid (PA) eliminates the band corresponding to PP-IP4 but 742 
has no effect on IP6. Other arrows indicate bands corresponding to ATP and IP3.  743 
D. Optimum pH for TbIPMK activity is within the physiological range.  744 
E. TbIPMK can only phosphorylate positions 3 and 6 of different IP5 derivatives to generate IP6. Note 745 
the lower synthesis of PP-IP4 using I(1,3,4,5,6)P5 as substrate compared to results obtained in (B) and 746 
(C). We observed that shorter enzymatic reaction time resulted in less PP-IP4 synthesis.  747 
All results are representative of three or more independent experiments. 748 
 749 
Fig. 3. TbIPMK, and TbIP5K complementation of yeast mutants.  750 
A. HPLC analysis of soluble inositol phosphates of S. cerevisiae arg82 mutants transformed with an 751 
empty vector (red) or a vector containing the entire open reading frame of TbIPMK (blue), and 752 
compared to those of wild-type (WT) yeast transformed with empty vector (black).  753 
B. Growth of the same cells in liquid medium as estimated by measuring optical density at 660 nm. 754 
arg82Δ mutants had reduced growth, which was restored by expression of TbIPMK. Mean ± s.d. for 755 
three independent experiments, each one with 6 duplicates.  756 
C. WT, and arg82 transformed with empty vector or arg82 transformed with TbIPMK (serially 757 
diluted 10-fold, 106-10 cells/spot from left to right) were spotted on YPD plates and incubated at 30ºC 758 
for 2 days.  759 
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D. HPLC analysis of soluble inositol phosphates of Scipk1 mutants transformed with an empty vector 760 
(red) or a vector containing the entire open reading frame of TbIPMK (blue) and compared with wild 761 
type transformed with an empty vector (black).  762 
E. HPLC analysis of Scipk1Kcs1 complemented with empty vector (red) or TbIP5K (green) shows 763 
reconstitution of IP6 synthesis. In black, wild type transformed with empty vector.  764 
All results are representative of three or more independent experiments. 765 
 766 
Fig. 4. TbIP6K activity and complementation of yeast mutants.  767 
A. Kinase reactions performed with recombinant TbIP6K (2 µg) using the indicated substrates at 150 768 
µM for 1 hour at 37ºC. TbIP6K can phosphorylate I(1,3,4,5,6)P5 to PP-IP4 and IP6 to produce IP7 769 
(5PP-IP5) but cannot phosphorylate IP7 to produce IP8. Other arrows show bands corresponding to 770 
ATP, and IP5.  771 
B. HPLC analysis of soluble inositol phosphates of S. cerevisiae kcs1 mutants transformed with an 772 
empty vector (red) or a vector containing the entire open reading frame of TbIP6K (blue).  773 
C. Growth of the same cells in liquid medium as estimated by measuring optical density at 660 nm. 774 
kcs1 mutants had reduced growth, which was restored by expression of TbIP6K. Mean ± s.d. for 775 
three independent experiments, each one with 6 duplicates.  776 
D. WT, and kcs1 transformed with empty vector or kcs1 transformed with TbIP6K (serially diluted 777 
10-fold, 106-10 cells/spot from left to right) were spotted on YPD plates and incubated at 30ºC for 2 778 
days.  779 
E. Optimum pH for TbIP6K activity is under acidic conditions. We detected a higher activity at pH 6.0 780 
and 6.5.  781 
All results are representative of three or more independent experiments. 782 
 783 
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Fig. 5. HPLC and PAGE analyses of soluble inositol phosphates from T. brucei PCF and BSF.  784 
A. PCF showed the presence of IP, IP2, IP3 and IP6.  785 
B. BSF showed the presence of IP, and IP2. Cells were labeled with [
3H]inositol as described under 786 
Experimental Procedures.  787 
C-E. PAGE analyses of extracts from PCF (C) or BSF (D) or standard IP6 (E). Samples in (C) and (D) 788 
(5 x 109 cells) were treated with phytase (Phy) (0.1 mg/ml, pH 5.0, at 37ºC for 1 hour) to confirm that 789 
the bands correspond to IP6.  790 
E. Phytase control activity with IP6 standard.  791 
All results are representative of three or more independent experiments. 792 
 793 
Fig. 6. Phenotypic changes of mutant BSF deficient in TbIPMK.  794 
A. qRT-PCR analysis of gene expression of TbIPMK at time 0 and after 1 and 3 days in the absence of 795 
tetracycline as compared to expression of control actin. Values are means ± s.e.m., n = 3. P < 0.001 at 796 
days 1 and 3 without tetracycline. Student’s t test. 797 
B. In vitro growth of BSF in the presence (+Tet) or absence (-Tet) of 1 µM tetracycline. Values are 798 
means ± s.e.m., n = 3 (bars are smaller than symbols).  799 
C. Quantification of short-chain polyphosphate in control (+Tet) and induced (-Tet) TbIPMK 800 
conditional knockout BSF. Values are means ± s.e.m, n = 3, *P < 0.05. Student’s t test. 801 
D. Numeric distribution of acidocalcisomes in BSF. Whole unfixed parasites were observed by 802 
transmission electron microscopy and the number of acidocalcisomes per cell in ~100 cells of control 803 
(+Tet) and conditional TbIPMK mutants (-Tet) were counted (the results from 3 independent 804 
experiments were combined).  805 
E, F. Scanning transmission electron microscopy (STEM) images from control (E) or TbIPMK 806 
conditional mutant BSF showing acidocalcisomes. Bar = 1 µm. Insets show acidocalcisomes 807 
highlighted in (E) and (F) at higher magnification. Bars = 0.5 µm.   808 
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